- AdventHealth Research Institute
For decades, Type 1 diabetes (T1D) was perceived as a condition that appeared suddenly, transforming a person's life overnight. However, recent research is uncovering a different reality. Scientists have found that T1D develops gradually, often over several years, as the body's immune system begins to attack the insulin-producing cells in the pancreas. This important discovery has paved the way for an extraordinary possibility: the potential for prevention.
At AdventHealth’s Translational Research Institute (TRI) and centers across the country, researchers, scientists, and clinicians are studying ways to identify T1D before symptoms even appear. Through simple blood tests that look for autoantibodies, markers that show the immune system is active against insulin-producing cells, researchers can now detect the earliest signs of the disease, sometimes years before diagnosis.
This early detection means intervention is finally possible. Ongoing studies are exploring new treatments that could protect the pancreas, slow the immune attack, or even stop it entirely. It’s a radical shift moving from waiting to treat diabetes after it develops to finding ways to keep it from starting at all.
For families, that message brings hope. For those who already live with T1D, it means a future where children and grandchildren might never have to face it. For those at risk, it means having time to prepare, monitor, and participate in prevention studies that could make a lasting difference.
What You Can Do This Diabetes Awareness Month
1. Learn your risk.
If someone in your family has T1D, you can get screened for diabetes-related autoantibodies. These tests can reveal your risk level long before symptoms begin.
2. Pay attention to symptoms.
Excessive thirst, frequent urination, fatigue, or unexpected weight loss can all be early signs of diabetes. If you or your child experiences these, see a healthcare provider right away.
3. Support research.
Clinical studies rely on volunteers, both those with and without diabetes, to advance prevention and treatment. Participating or donating helps fuel discoveries that bring us closer to a world without T1D.
4. Share what you learn.
Awareness starts with conversation. Sharing accurate information about prevention and early testing could help someone you know detect diabetes before it becomes dangerous.
Prevention is no longer a far-off dream. Scientists are learning how to recognize T1D before it takes hold, and families are stepping up to be part of that change. Every test, every trial, every conversation brings us closer to a future where T1D may never have a chance to begin.
Recent News
Bringing Cancer Research Into the Home: Dr. Justin Brown's Approach to Trial Design
Justin Brown, PhD, Associate Investigator at AdventHealth, has dedicated his career to studying how exercise can improve outcomes for cancer patients after losing his father to colon cancer as a...
Exercise as “Powerful Medicine”: Spotlight on AdventHealth Research
Recently, Dr. Bret Goodpaster, scientific director of the AdventHealth Translational Research Institute (TRI), appeared on FOX 35 News to discuss groundbreaking research exploring how exercise impacts...
New Study Points to Promising Way to Protect Kidneys in Type 1 Diabetes
Richard E. Pratley, M.D., senior investigator and diabetes program lead at the AdventHealth Translational Research Institute (TRI), served as one of the lead researchers on the international FINE-ONE...
Understanding Hypoglycemia and the CLEAR Study
The CLEAR Study is a groundbreaking, international research effort funded by the NIH that aims to help people with Type 1 diabetes (T1D) who can no longer sense when their blood sugar is dangerously...
Recognizing the Unrecognized: Advancing Research in Childhood Sjögren’s Disease
Sjögren’s disease has been recognized in adults for almost a century, first described by Swedish ophthalmologist Henrik Sjögren in the early 20th century. One of the biggest challenges in recognizing...
Did you know? Women, Hormones, and Heart Risk
Heart disease is often thought of as a “man’s disease,” but it remains the leading cause of death for women in the United States. We asked Katie Love, MD, MSc, an investigator at the AdventHealth...
Weight-Loss Drugs, Hormones, and Midlife: What Women Need to Know
Understanding the connection between GLP-1 medications and hormone therapy
Women, Brain Health, and the Alzheimer’s Puzzle
Why scientists are taking a closer look at why women face higher Alzheimer’s risk
Clinical Trial Evidence on Diet and Type 1 Diabetes Outcomes
A new systematic review of clinical trials has found that no single dietary pattern consistently improves blood sugar control or weight management in youth and adults living with type 1 diabetes.
How Diet Shapes Gut Microbes and Energy Absorption
What we eat has a big impact on the bacteria living in our gut, which in turn affects how our bodies use energy—something that plays a major role in the development and treatment of obesity.
AdventHealth Neuroscience Institute Launches NIH-Funded THRIVE Trial
AdventHealth Neuroscience Institute has launched THRIVE, an NIH-funded clinical trial led by Lauren Oberlin, PhD, geriatric neuropsychologist and neuroscience researcher.
AdventHealth Tampa Enrolls First Patient in the Tectonic CAD IVL Trial
On September 19, 2025, AdventHealth Tampa successfully enrolled its first patient in the Tectonic CAD Intravascular Lithotripsy (IVL) Trial, led by Dr. Mahmaljy and his team.